Video: EURODIS – Improving Global Access to Orphan Medicinal Products

In Market Access by Cameron

Yann Le Camm, Chief Executive Officer for EURORDIS, gave us his take on what needs to be done to improve global access to orphan drugs at the 2013 World Orphan Drugs Congress Europe.

The annual World Orphan Drug Congress Europe is the region’s largest event dedicated to scientific, commercialisation and business development: an exhibition, a strategic keynote conference and real life case studies. This year’s event will take place from the 12th to the 14th of November.

The European Organization for Rare Diseases (EURORDIS) is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, that promotes research on rare diseases and commercial development of orphan drugs